18F-FDG PET-CT在评价肺癌化疗疗效中的应用

The application of 18F-FDG PET-CT in evaluation of the value of lung cancer chemotherapy

  • 摘要: 肺癌是全世界目前最常见的因肿瘤致死的原因之一,化疗是治疗晚期非小细胞肺癌(NSCLC)及小细胞肺癌(SCLC)的主要手段,且近年来已逐渐应用于NSCLC的早期和中期阶段的治疗。随着新技术的发展,18F-FDG PET-CT逐渐应用于肺癌患者的化疗疗效和预后评价中,该文综述了18FDG PET-CT在肺癌化疗中的应用。

     

    Abstract: Lung cancer has become the leading cause of cancer-related death in the world, chemotherapy plays an important role in the treatment of advanced non-small cell lung cancer (NSCLC) and small cell lung carcinoma(SCLC), and now is gradually applied in the early and middle stage of NSCLC. With the development of new technology, 18F-FDG PET-CT is applied in evaluation of chemotherapy effect and prognosis in patients with lung cancer. The application of 18F-FDG PET-CT in the lung cancer chemotherapy are reviewed in this paper.

     

/

返回文章
返回